Treatment with tretinoin induces a robust anti-tumor CD8+ T cell response, increasing proliferation, expression of effector molecules IFNγ, granzyme B and perforin, as well as activation and cell migration markers [17, 18]. The gene discussed is CD8A; the disease is neoplasm.